|
|
|
|
Molecular Pharmacology, Vol 14, 357-365, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology, Northwestern University, Chicago, Illinois 60611
2 Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706
A partially purified extract of Solanum malacoxylon was tested for its actions on fetal
rat bone in vitro. The extract had a biphasic effect on bone resorption in vitro,
stimulating at low concentrations (0.3-0.3 mg/ml) and inhibiting at concentrations of 1
mg/ml and higher. The stimulatory effect could be antagonized with calcitonin or
glucagon. At a concentration of 1.0 mg/ml, the S. malacoxylon extract antagonized the
bone-resorbing effects of l
,25-dihydroxyvitamin D3[1,25-(OH)2D3] and parathyroid
hormone. To determine whether effects in vitro could be due to 1,25-(OH)2D3 released
into the medium during incubation, bones were cultured with equieffective concentrations of parathyroid hormone, 1,25-(OH)2D3, or S. malacoxylon, and the culture
medium was extracted with organic solvents. Chloroform or benzene extracts from
control or parathyroid hormone treated cultures were inactive, whereas those from
1,25-(OH)2D3-treated cultures retained most or all of the activity of the original media.
Benzene extracts of S. malacoxylon culture, media inhibited resorption. The inhibitory
material could be removed by high-pressure liquid chromatography, but the benzene
extract was still ineffective. The results would be consistent with S. malacoxylon
acting in vitro as the unhydrolyzed glycoside conjugate. However, it is also possible
that the bone cells hydrolyze the glycoside to release small amounts of 1,25-(OH)2D3,
which then interacts with the receptor.
Note:
ACKNOWLEDGMENTS
We would like to express our appreciation to Jan
Miller and Thalia Mavreas for their excellent technical assistance, and to Lorraine Reeve and Michael
Holick for providing the S. malacoxylon extract
used in these studies.